Harvard is studying the impact of weed on menstrual pain. A researcher at Harvard will study the effects of cannabis suppositories in a trial consisting of 400 women.
The study will survey women over the course of several months who will use the suppositories and record their symptoms. The study is partnering with cannabis brand Foria, which produces weed-infused lotions, sprays, and suppositories, designed to help women with everything from treating menstrual pain and having better orgasms.
“Women have been saying [cannabis] works for 10,000 years, and I don’t think men have been listening,” stated Foria CEO Mathew Gerson to Business Insider.
Staci Gruber, a professor of psychiatry at Harvard who will run the study, said in an interview with Business Insider that the observational study is the first step toward a clinical trial. However, an application for a clinical trial can take years to be approved and weed used for research must be obtained through NIDA, which researchers have pointed out is a poor quality, low-THC product.
So, for now, the study will use weed from Foria’s product line.
“What actually made this market was empathy,” Gerson said. “We serve the plant, we serve our clients, and as a result our investment community and the people that support our brand benefit from that.”